| Bioactivity | MART-1 (26-35) (human) TFA is amino acid residue 26 to 35 of MART-1 protein. | ||||||
| Invitro | MART-1 (Melan-A) gene is 18 kb long and comprises five exons. It is expressed in most melanoma tumor samples, and among normal cells, only in melanocytes [1] . In cancer immunotherapy, epitopes and variants derived from the MART-1/Melan-A protein are widely used as clinical vaccines. The epitopes spanning amino acid residues 26–35 and 27–35 from the MART-1/Melan-A protein, highly expressed in melanoma cells, provide a prime example of T cell recognition of multiple peptides and the use of peptide variants designed to elicit altered immunological responses [2] . | ||||||
| Name | MART-1 (26-35) (human) TFA | ||||||
| Sequence | Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val | ||||||
| Shortening | EAAGIGILTV | ||||||
| Formula | C44H75F3N10O16 | ||||||
| Molar Mass | 1057.12 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |